Helius Medical Technologies Inc. (TSX: HSM) (NASDAQ: HSDT) Featured in Virtual Coverage of the Summer Investor Summit 2020
Helius Medical Technologies (TSX: HSM) (NASDAQ: HSDT) is a neurotech company focused on neurological wellness. The company's purpose is to develop, license and acquire unique and non-invasive platform technologies that amplify the brain's ability to heal itself. The company's first product in development is the Portable Neuromodulation Stimulator (PoNS™). The stimulator delivers neurostimulation via the tongue, which has been shown in clinical studies to improve the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. For more information, visit the company's website at www.heliusmedical.com To view IBN’s virtual coverage of…







